vs

Side-by-side financial comparison of CHOICEONE FINANCIAL SERVICES INC (COFS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $42.9M, roughly 1.8× CHOICEONE FINANCIAL SERVICES INC). On growth, CHOICEONE FINANCIAL SERVICES INC posted the faster year-over-year revenue change (76.4% vs 27.7%). CHOICEONE FINANCIAL SERVICES INC produced more free cash flow last quarter ($25.2M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.0%).

ChoiceOne Financial Services Inc is a US regional financial holding company that operates through its banking subsidiary, offering personal and commercial banking products including savings accounts, loans, wealth management, and insurance services primarily to consumers, small businesses, and corporate clients across Michigan.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

COFS vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.8× larger
PBYI
$75.5M
$42.9M
COFS
Growing faster (revenue YoY)
COFS
COFS
+48.7% gap
COFS
76.4%
27.7%
PBYI
More free cash flow
COFS
COFS
$10.8M more FCF
COFS
$25.2M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
15.0%
COFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COFS
COFS
PBYI
PBYI
Revenue
$42.9M
$75.5M
Net Profit
Gross Margin
69.3%
Operating Margin
39.1%
22.7%
Net Margin
Revenue YoY
76.4%
27.7%
Net Profit YoY
EPS (diluted)
$1.43
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COFS
COFS
PBYI
PBYI
Q4 25
$42.9M
$75.5M
Q3 25
$61.8M
$54.5M
Q2 25
$60.4M
$52.4M
Q1 25
$44.9M
$46.0M
Q4 24
$24.3M
$59.1M
Q3 24
$36.6M
$80.5M
Q2 24
$34.0M
$47.1M
Q1 24
$32.5M
$43.8M
Net Profit
COFS
COFS
PBYI
PBYI
Q4 25
Q3 25
$14.7M
$8.8M
Q2 25
$13.5M
$5.9M
Q1 25
$-13.9M
$3.0M
Q4 24
Q3 24
$7.3M
$20.3M
Q2 24
$6.6M
$-4.5M
Q1 24
$5.6M
$-4.8M
Gross Margin
COFS
COFS
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
COFS
COFS
PBYI
PBYI
Q4 25
39.1%
22.7%
Q3 25
29.6%
17.6%
Q2 25
27.6%
12.7%
Q1 25
-39.2%
8.7%
Q4 24
36.1%
22.6%
Q3 24
25.4%
27.4%
Q2 24
24.0%
-4.6%
Q1 24
21.1%
-5.3%
Net Margin
COFS
COFS
PBYI
PBYI
Q4 25
Q3 25
23.7%
16.2%
Q2 25
22.4%
11.2%
Q1 25
-31.0%
6.5%
Q4 24
Q3 24
20.1%
25.2%
Q2 24
19.4%
-9.6%
Q1 24
17.3%
-11.0%
EPS (diluted)
COFS
COFS
PBYI
PBYI
Q4 25
$1.43
$0.26
Q3 25
$0.97
$0.17
Q2 25
$0.90
$0.12
Q1 25
$-1.29
$0.06
Q4 24
$0.79
$0.40
Q3 24
$0.85
$0.41
Q2 24
$0.87
$-0.09
Q1 24
$0.74
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COFS
COFS
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$88.0M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$465.4M
$130.3M
Total Assets
$4.4B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COFS
COFS
PBYI
PBYI
Q4 25
$88.0M
$97.5M
Q3 25
$99.0M
$94.4M
Q2 25
$156.3M
$96.0M
Q1 25
$139.4M
$93.2M
Q4 24
$96.8M
$101.0M
Q3 24
$145.9M
$96.7M
Q2 24
$101.0M
$96.8M
Q1 24
$150.1M
$107.2M
Total Debt
COFS
COFS
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
COFS
COFS
PBYI
PBYI
Q4 25
$465.4M
$130.3M
Q3 25
$449.6M
$115.3M
Q2 25
$431.8M
$104.7M
Q1 25
$427.1M
$97.1M
Q4 24
$260.4M
$92.1M
Q3 24
$247.7M
$71.1M
Q2 24
$214.5M
$48.5M
Q1 24
$206.8M
$51.0M
Total Assets
COFS
COFS
PBYI
PBYI
Q4 25
$4.4B
$216.3M
Q3 25
$4.3B
$202.9M
Q2 25
$4.3B
$194.9M
Q1 25
$4.3B
$196.2M
Q4 24
$2.7B
$213.3M
Q3 24
$2.7B
$220.7M
Q2 24
$2.7B
$205.0M
Q1 24
$2.7B
$214.1M
Debt / Equity
COFS
COFS
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COFS
COFS
PBYI
PBYI
Operating Cash FlowLast quarter
$31.8M
$14.4M
Free Cash FlowOCF − Capex
$25.2M
$14.4M
FCF MarginFCF / Revenue
58.7%
19.1%
Capex IntensityCapex / Revenue
15.4%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COFS
COFS
PBYI
PBYI
Q4 25
$31.8M
$14.4M
Q3 25
$15.3M
$9.7M
Q2 25
$9.0M
$14.1M
Q1 25
$-6.5M
$3.6M
Q4 24
$47.1M
$15.6M
Q3 24
$-7.4M
$11.0M
Q2 24
$15.7M
$1.0M
Q1 24
$15.3M
$11.2M
Free Cash Flow
COFS
COFS
PBYI
PBYI
Q4 25
$25.2M
$14.4M
Q3 25
$13.7M
$9.7M
Q2 25
$6.9M
$14.1M
Q1 25
$-7.3M
$3.6M
Q4 24
$45.4M
$15.6M
Q3 24
$-7.6M
$11.0M
Q2 24
$15.3M
$1.0M
Q1 24
$15.0M
FCF Margin
COFS
COFS
PBYI
PBYI
Q4 25
58.7%
19.1%
Q3 25
22.1%
17.7%
Q2 25
11.4%
26.8%
Q1 25
-16.3%
7.7%
Q4 24
186.4%
26.4%
Q3 24
-20.8%
13.7%
Q2 24
44.8%
2.1%
Q1 24
46.2%
Capex Intensity
COFS
COFS
PBYI
PBYI
Q4 25
15.4%
0.0%
Q3 25
2.6%
0.0%
Q2 25
3.4%
0.0%
Q1 25
1.9%
0.1%
Q4 24
7.0%
0.0%
Q3 24
0.7%
0.0%
Q2 24
1.4%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
COFS
COFS
PBYI
PBYI
Q4 25
Q3 25
1.04×
1.10×
Q2 25
0.66×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
-1.00×
0.54×
Q2 24
2.39×
Q1 24
2.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons